RAVI CHINTHAKINDI: Open Payments
NPI 1699940379 · LINCOLN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 27 payments from 15 companies in 2025. Trend: 2023 $293 · 2024 $531 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| Boston Scientific Corporation | 3 | $82 |
| Exact Sciences Corporation | 2 | $61 |
| PFIZER INC. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $45 |
| Cipher Pharmaceuticals US LLC | 1 | $31 |
| Amgen Inc. | 1 | $30 |
| UCB, Inc. | 1 | $30 |
Products named: CAPLYTA, WATCHMAN FLX, PREVNAR 20, REXULTI, ZENPEP, The Cologuard Plus Collection Kit, Natroba, EVENITY.
Industry payments across CA — which companies pay providers there.
